Highly interestingly, Moreira and colleagues demonstrated that CLAs, which are frequently used in dietary supplementation and known to activate PPARγ, have efficient anti-inflammatory effects that prevent colitis, but worsen colorectal cancer formation. Here, PPARG is linked to colorectal cancer.